When Less Is Not More: Exploring the Current Evidence, Practices, and Perspectives on Fluid Restriction in Patients with Heart Failure

Fluid restriction has long been a cornerstone of heart failure (HF) management, traditionally recommended at 1.5-2 liters/day for patients with advanced HF or hyponatremia to prevent volume overload. It was based on the rationale that limiting fluid intake reduces preload, alleviates congestion, and counteracts neurohormonal activation. However, this practice has been driven more by clinical judgement and physiological reasoning than high-quality evidence. Recently, emerging data have challenged its universal use, raising concerns about quality of life, adherence, and dehydration risk. This narrative review explores the evolving role of fluid restriction in chronic HF, with a focus on the balance between physiological rationale and patient-centered outcomes. It critically examines historical practices, summarizes key clinical trials, including the Fluid Restriction in Heart Failure versus Liberal Fluid Uptake (FRESH-UP) trial, and evaluates the risks of both fluid overload and dehydration. The review further considers current guideline positions, highlights gaps in evidence, and discusses emerging perspectives that advocate for a more individualized, quality-of-life-oriented approach to fluid management in HF. Evidence supporting routine fluid restriction has been limited and inconsistent. While small studies suggested possible benefits in hyponatremic patients, others reported minimal clinical impact and increased thirst. The FRESH-UP trial, the largest to date, found that liberal, thirst-guided fluid intake was safe and reduced thirst distress without increasing hospitalizations, mortality, or renal dysfunction. These results challenge routine restriction and support a more individualized approach. Emerging evidence suggests that strict fluid restriction offers little clinical benefit for most stable chronic HF patients. A more liberal, individualized approach improves comfort without compromising safety and reflects the evolving direction of HF care.

Authors

Institutions

Publication Details

Journal
Cardiology in Review
Published
2025-09-19
DOI
https://doi.org/10.1097/crd.0000000000001059
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When Less Is Not More: Exploring the Current Evidence, Practices, and Perspectives on Fluid Restriction in Patients with Heart Failure

Hritvik Jain, Rakendu Jayasree Rajendran, Siddharth Pravin Agrawal, Nadeem Ashraf et al.
Cardiology in Review
Heart Failure Treatment and Management
article

When Less Is Not More: Exploring the Current Evidence, Practices, and Perspectives on Fluid Restriction in Patients with Heart Failure

Hritvik Jain, Rakendu Jayasree Rajendran, Siddharth Pravin Agrawal, Nadeem Ashraf, Darshilkumar Maheta, Dhruvi Kalpesh Joshi, William H. Frishman, Rushin S. Shah, Jaisingh Rajput, Dhruvi S. Patel, Wilbert S. Aronow
article en

Abstract

Fluid restriction has long been a cornerstone of heart failure (HF) management, traditionally recommended at 1.5-2 liters/day for patients with advanced HF or hyponatremia to prevent volume overload. It was based on the rationale that limiting fluid intake reduces preload, alleviates congestion, and counteracts neurohormonal activation. However, this practice has been driven more by clinical judgement and physiological reasoning than high-quality evidence. Recently, emerging data have challenged its universal use, raising concerns about quality of life, adherence, and dehydration risk. This narrative review explores the evolving role of fluid restriction in chronic HF, with a focus on the balance between physiological rationale and patient-centered outcomes. It critically examines historical practices, summarizes key clinical trials, including the Fluid Restriction in Heart Failure versus Liberal Fluid Uptake (FRESH-UP) trial, and evaluates the risks of both fluid overload and dehydration. The review further considers current guideline positions, highlights gaps in evidence, and discusses emerging perspectives that advocate for a more individualized, quality-of-life-oriented approach to fluid management in HF. Evidence supporting routine fluid restriction has been limited and inconsistent. While small studies suggested possible benefits in hyponatremic patients, others reported minimal clinical impact and increased thirst. The FRESH-UP trial, the largest to date, found that liberal, thirst-guided fluid intake was safe and reduced thirst distress without increasing hospitalizations, mortality, or renal dysfunction. These results challenge routine restriction and support a more individualized approach. Emerging evidence suggests that strict fluid restriction offers little clinical benefit for most stable chronic HF patients. A more liberal, individualized approach improves comfort without compromising safety and reflects the evolving direction of HF care.

Cardiology in Review
University of Tennessee Health Science Center (US), New York Medical College (US), All India Institute of Medical Sciences Jodhpur (IN), Baptist Health System (US), Virtua Health (US), Smt. N.H.L. Municipal Medical College (IN), B.J. Medical College (IN)
Openalex Percentile: Top 61%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.